COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 2385: Articles 23841-23850  | Next

Pediatric intensive care unit admissions for COVID-19: insights using state level data
Loomba, R. S., Villarreal, E. G., Farias, J. S., Bronicki, R. A., Flores, S.
10.1101/2020.07.22.20160226 — Posted: 2020-07-24
Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US
Schneeweiss, M. C., Leonard, S., Weckstein, A., Schneeweiss, S., Rassen, J.
10.1101/2020.07.22.20159855 — Posted: 2020-07-24
Evidence for immunity to SARS-CoV-2 from epidemiological data series
Yubero, P., Lavin, A. A., Poyatos, J. F.
10.1101/2020.07.22.20160028 — Posted: 2020-07-24
The Optimal Allocation of Covid-19 Vaccines
Babus, A., Das, S., Lee, S.
10.1101/2020.07.22.20160143 — Posted: 2020-07-24
The collective wisdom in the COVID-19 research: comparison and synthesis of epidemiological parameter estimates in preprints and peer-reviewed articles
Wang, Y., Cao, Z., Zeng, D., Zhang, Q., Luo, T.
10.1101/2020.07.22.20160291 — Posted: 2020-07-24
Decreasing median age of COVID-19 cases in the United States: changing epidemiology or changing surveillance?
Greene, D. N., Jackson, M. L., Hillyard, D. R., Delgado, J. C., Schmidt, R. L.
10.1101/2020.07.22.20160119 — Posted: 2020-07-24
An analysis of mortality in Ontario using cremation data: Rise in cremations during the COVID-19 Pandemic
Postill, G., Murray, R., Wilton, A., Wells, R. A., Sirbu, R., Daley, M. J., Rosella, L. C.
10.1101/2020.07.22.20159913 — Posted: 2020-07-24
Using mobile phone data for epidemiological simulations of lockdowns: government interventions, behavioral changes, and resulting changes of reinfections
Müller, S. A., Balmer, M., Charlton, B., Ewert, R., Neumann, A., Rakow, C., Schlenther, T., Nagel, K.
10.1101/2020.07.22.20160093 — Posted: 2020-07-24
Circulating cytokines and lymphocyte subsets in patients who have recovered from COVID-19
None, H., Zhang, X., Li, X., Li, X., Li, D.
10.1101/2020.07.22.20160259 — Posted: 2020-07-24 Discussion: Onsite | Offsite
Remdesivir for COVID-19: match-population analysis with compassionate use of Remdesivir for severe COVID-19
Vasylyeva, O., Chen, T., Hanna, J.
10.1101/2020.07.22.20160002 — Posted: 2020-07-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).